Antibody-Independent Function of Human B Cells Contributes to Antifungal T Cell Responses

Cytokine-Defined B Cell Responses as Therapeutic Targets in Multiple Sclerosis

(2016) Rui Li et al.   Frontiers in Immunology

Anti-CD20 Antibody Therapy and Susceptibility to Pneumocystis Pneumonia

(2015) Waleed Elsegeiny et al.   INFECTION AND IMMUNITY

Delinking CARD9 and IL-17: CARD9 Protects againstCandida tropicalisInfection through a TNF-α–Dependent, IL-17–Independent Mechanism

(2015) Natasha Whibley et al.   JOURNAL OF IMMUNOLOGY

Proinflammatory GM-CSF–producing B cells in multiple sclerosis and B cell depletion therapy

(2015) Rui Li et al.   Science Translational Medicine

CARD9 Deficiency and Spontaneous Central Nervous System Candidiasis: Complete Clinical Remission With GM-CSF Therapy

(2014) C. Gavino et al.   CLINICAL INFECTIOUS DISEASES

From the regulatory functions of B cells to the identification of cytokine-producing plasma cell subsets

(2014) Van Duc Dang et al.   CURRENT OPINION IN IMMUNOLOGY

Oral-resident natural Th17 cells and γδ T cells control opportunisticCandida albicansinfections

(2014) Heather R. Conti et al.   JOURNAL OF EXPERIMENTAL MEDICINE

IL-35-producing B cells are critical regulators of immunity during autoimmune and infectious diseases

(2014) Ping Shen et al.   NATURE

A Novel MicroRNA-132-Surtuin-1 Axis Underlies Aberrant B-cell Cytokine Regulation in Patients with Relapsing-Remitting Multiple Sclerosis

(2014) Yusei Miyazaki et al.   PLoS One

Brothers in Arms: Th17 and Treg Responses in Candida albicans Immunity

(2014) Natasha Whibley et al.   PLoS Pathogens

Should Pneumocystis jiroveci prophylaxis be recommended with Rituximab treatment in ANCA-associated vasculitis?

(2013) Emilio Besada et al.   CLINICAL RHEUMATOLOGY

MHC class II–dependent B cell APC function is required for induction of CNS autoimmunity independent of myelin-specific antibodies

(2013) Nicolas Molnarfi et al.   JOURNAL OF EXPERIMENTAL MEDICINE

Th17 Cells in Immunity to Candida albicans

(2012) Nydiaris Hernández-Santos et al.   Cell Host & Microbe

Pneumocystis Pneumonia in Patients Treated With Rituximab

(2012) Isabel Martin-Garrido et al.   CHEST

Immunity to infection in IL-17-deficient mice and humans

(2012) Sophie Cypowyj et al.   EUROPEAN JOURNAL OF IMMUNOLOGY

B cell depletion therapy ameliorates autoimmune disease through ablation of IL-6–producing B cells

(2012) Tom A. Barr et al.   JOURNAL OF EXPERIMENTAL MEDICINE

Th17 cells confer long-term adaptive immunity to oral mucosal Candida albicans infections

(2012) N Hernández-Santos et al.   Mucosal Immunology

Diagnostic criteria for multiple sclerosis: 2010 Revisions to the McDonald criteria

(2011) Chris H. Polman et al.   ANNALS OF NEUROLOGY

The anti-CD20 antibody rituximab reduces the Th17 cell response

(2011) Frank L. van de Veerdonk et al.   ARTHRITIS AND RHEUMATISM

Interleukin-12 Receptor  1 Deficiency Predisposing to Disseminated Coccidioidomycosis

(2011) D. C. Vinh et al.   CLINICAL INFECTIOUS DISEASES

IL-17A and IL-17F Expression in B Lymphocytes

(2011) Alejandro Vazquez-Tello et al.   INTERNATIONAL ARCHIVES OF ALLERGY AND IMMUNOLOGY

Gain-of-function humanSTAT1mutations impair IL-17 immunity and underlie chronic mucocutaneous candidiasis

(2011) Luyan Liu et al.   JOURNAL OF EXPERIMENTAL MEDICINE

Chronic Mucocutaneous Candidiasis in Humans with Inborn Errors of Interleukin-17 Immunity

(2011) A. Puel et al.   SCIENCE

IL-6: Regulator of Treg/Th17 balance

(2010) Akihiro Kimura et al.   EUROPEAN JOURNAL OF IMMUNOLOGY

Does rituximab increase the incidence of infectious complications? A narrative review

(2010) Theodoros Kelesidis et al.   INTERNATIONAL JOURNAL OF INFECTIOUS DISEASES

Revisiting Human IL-12Rβ1 Deficiency

(2010) Ludovic de Beaucoudrey et al.   MEDICINE

Rituximab-Associated Infections

(2010) Juan C. Gea-Banacloche   SEMINARS IN HEMATOLOGY

Pneumocystis jiroveci pneumonia following rituximab treatment in Wegener's granulomatosis

(2010) Boris Hugle et al.   ARTHRITIS CARE & RESEARCH

Incidence and Predictive Factors for Infectious Disease after Rituximab Therapy in Kidney-Transplant Patients

(2009) N. Kamar et al.   AMERICAN JOURNAL OF TRANSPLANTATION

Abnormal B-cell cytokine responses a trigger of T-cell-mediated disease in MS?

(2009) Amit Bar-Or et al.   ANNALS OF NEUROLOGY

Refractory Disseminated Coccidioidomycosis and Mycobacteriosis in Interferon‐γ Receptor 1 Deficiency

(2009) Donald C. Vinh et al.   CLINICAL INFECTIOUS DISEASES

Th17 cells and IL-17 receptor signaling are essential for mucosal host defense against oral candidiasis

(2009) Heather R. Conti et al.   JOURNAL OF EXPERIMENTAL MEDICINE

Th1-Th17 Cells Mediate Protective Adaptive Immunity against Staphylococcus aureus and Candida albicans Infection in Mice

(2009) Lin Lin et al.   PLoS Pathogens

Mice lacking both G-CSF and IL-6 are more susceptible toCandida albicansinfection: Critical role of neutrophils in defense againstCandida albicans

(2008) Sunanda Basu et al.   GROWTH FACTORS

Pneumocystis jiroveci Pneumonia in Patients with Non-Hodgkin's Lymphoma Receiving Chemotherapy Containing Rituximab

(2008) Hung Chang et al.   Journal of the Chinese Medical Association

Impaired TH17 cell differentiation in subjects with autosomal dominant hyper-IgE syndrome

(2008) Joshua D. Milner et al.   NATURE